Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?

Every huge drugmaker was once a much smaller drugmaker. We don't even have to go back too many years to see where Eli Lilly (LLY 1.13%) and Novo Nordisk (NVO 0.39%), currently the two biggest pharma companies on the planet, were only a fraction of their current sizes. The main way small drugmakers become large is by launching successful new products. Madrigal Pharmaceuticals (MDGL 4.76%) should soon have its first taste of such success with the U.S. Food and Drug Administration (FDA) approving Rezdiffra for ...